• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library

    FDA Rejects Disc’s Rare Blood Disease Drug Amid Reports of Prasad

    BIOSPACE

    Lilly`s Retevmo Delivers Substantial Event-Free Survival Benefit

    PR NEWSWIRE

    USFDA Issues Form 483 With 6 Observations To Enzene Biosciences`

    INDPHARMAPOST

    Zemcelpro (Dorocubicel) Receives NUB Status 1 In Germany

    PR NEWSWIRE

    Roche Announces Positive Phase III Results For Gazyva/Gazyvaro

    GLOBENEWSWIRE

    Lupin Signs Supply Deal To Launch Antidepressant In Canada

    PRESS RELEASE

    Mankind Pharma Reinvents Global Supply Chain And Procurement

    EXPRESSPHARMA

    Beyfortus study published in The Lancet Infectious Diseases

    PRESS RELEASE

    Medical groups urge US judge to block vaccine policy shifts

    REUTERS

    CPRIT`s $6B Cancer Program Awaits Public Evaluation

    GLOBENEWSWIRE

    Adven Biotech: India`s First NABL-Accredited Homeopathy Brand

    ECONOMICTIMES

    Torrent Pharma Q3 Profit at Rs 577 Cr, 9-Month Rs 1,725 Cr

    INDPHARMAPOST

    CStone Advances Trispecific Antibody CS2009 To Phase II Trial

    PR NEWSWIRE

    GST Rejig Signals Shift to Affordable Cancer Care at AIIMS

    ECONOMICTIMES

    Sapu Bioscience Expands International IP Coverage for OT-101

    GLOBENEWSWIRE

    Zydus Gets USFDA Nod For Ammonium Lactate Cream 12%

    INDPHARMAPOST

    NATCO Receives CDSCO Approval For Semaglutide In India

    INDPHARMAPOST

    Ayush Export Declines By 7.4% In First Nine Months Of FY 26

    PHARMABIZ

    Haryana FDA Raids Target Drugs in Hisar, Karnal, and Kalanwali

    PHARMABIZ

    PCI Asks Institutions To Submit SIF For 2026-27 By February 27

    PHARMABIZ

    Bioasia 2026 Positions Telangana As A Global Techbio Powerhouse

    INDPHARMAPOST

    Ultragenyx Pharma Investors With Losses Can Lead Class Action

    PHARMIWEB

    FDA Issues Form 483 with 4 Observations to Piramal

    BUSINESS STD

    India Becoming Backbone Of Global Clinical Research

    ECONOMICTIMES

    Alkem Labs Unit To Buy Up To 55% Of Occlutech For $118 Million

    ECONOMICTIMES

    Disc`s Rare Disease Drug Hit By FDA Rejection

    PRESS RELEASE

    Lupin Q3 FY26 Consolidated PAT Jumped 37.4% To Rs. 1,180.5 Cr

    PRESS RELEASE

    Supriya Lifescience Posts 11% YoY Q3 FY26 Growth

    INDPHARMAPOST

    Netramark Announces Uplisting To Toronto Stock Exchange

    GLOBENEWSWIRE

    Conavi Medical Showcases Benefits Of Hybrid IVUS-OCT Imaging

    GLOBENEWSWIRE

    HELUS Pharma Releases Q3 Fy2026 Financials And Business Updates

    GLOBENEWSWIRE

    Advanced Bio Announces Feasibility Study With Chi-Mei Center

    GLOBENEWSWIRE

    Sienna Announces February Dividend

    GLOBENEWSWIRE

    Indian Sceintists Intensify Research to Develop Rabies Vaccine

    PHARMABIZ

    Essilorluxottica Announces The Launch Of A Share Buyback Program

    GLOBENEWSWIRE

    Precision Optics Schedules Q2 FY2026 Earnings Call for Feb. 17

    GLOBENEWSWIRE

    Procurement Lessons From India`s Pharma Sector

    EXPRESSPHARMA

    Chemed Board OKs $300M Buyback, 60 cent Quarterly Dividend

    GLOBENEWSWIRE

    SRX Health Solutions Reveals Fiscal Q1 2026 Results

    GLOBENEWSWIRE

    Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq

    GLOBENEWSWIRE

    Heartflow To Release 2025 Financial Results On March 18, 2026

    GLOBENEWSWIRE

    Natural Alternatives Intl. Announces Q2 2026 YTD Results

    GLOBENEWSWIRE

    FDA Cites Firms For CGMP And Testing Violations

    RAPS

    Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule

    BUSINESSWIRE

    Cencora Closes $3.0 Billion Senior Notes Offering

    BUSINESSWIRE

    Enpro Increases Quarterly Dividend

    BUSINESSWIRE

    AMEEREX Acquires Corcoran Canyon 45.6M Oz Silver Project

    PHARMIWEB

    ADM Tronics Reports Third Quarter Of Fiscal Year 2026 Results

    PHARMIWEB

    Oracle Corp Faces Securities Fraud Lawsuit For 11% Stock Decline

    PHARMIWEB

    CellBxhealth PLC Aligns Regulatory Approach With Commercial Needs

    PHARMIWEB

    HYD LLc Validates 30-Year Deuterium Modulation Cancer Gene Study

    PR NEWSWIRE

    vTv Therapeutics to Participate in Upcoming Investor Conferences

    GLOBENEWSWIRE

    Vertex`s Journavx Painkiller Surpasses 500K Prescriptions

    BIOSPACE

    Vertex Sets Lofty $500M Revenue Goal For New Products In `26

    FIERCE PHARMA

    Valneva Updates IXCHIQ Recommendations in the UK

    GLOBENEWSWIRE

    Ultragenyx Lays Off 10% Of Workers As FDA Stalls Approval Plan

    FIERCE BIOTECH

    Nxera Pharma Announces Consolidated Q4 and Full Year 2025 Results

    GLOBENEWSWIRE

    Nxera Pharma Proposes Changes To Its Board Of Directors

    GLOBENEWSWIRE

    Sensient Tech Corp Releases Q4 2025 Results

    PHARMIWEB

    Scholar Rock Issues Employee Grants Per Nasdaq LR 5635(C)(4)

    BUSINESSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.